Textbook of Digital Health

Dr Chris Paton

← References

Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

Drug Enforcement Administration, Department of Health and Human Services (2025)

Federal Register.

URL: https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled

Abstract. Joint DEA and HHS temporary rule, published 31 December 2025, extending the COVID-era flexibilities that permit DEA-registered practitioners to prescribe Schedule II-V controlled substances via telemedicine without a prior in-person evaluation, effective 1 January 2026 through 31 December 2026.

Cited in